These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29755317)

  • 1. Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?
    Janda E; Boi L; Carta AR
    Front Mol Neurosci; 2018; 11():144. PubMed ID: 29755317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.
    Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM
    Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease.
    Park JY; Paik SR; Jou I; Park SM
    Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia in Parkinson's Disease.
    Ho MS
    Adv Exp Med Biol; 2019; 1175():335-353. PubMed ID: 31583594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial phagocytic clearance in Parkinson's disease.
    Tremblay ME; Cookson MR; Civiero L
    Mol Neurodegener; 2019 Apr; 14(1):16. PubMed ID: 30953527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
    Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
    FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia.
    Nash Y; Schmukler E; Trudler D; Pinkas-Kramarski R; Frenkel D
    J Neurochem; 2017 Dec; 143(5):584-594. PubMed ID: 28921554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
    Zhang QS; Heng Y; Yuan YH; Chen NH
    Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of microglial autophagy in Parkinson's disease.
    Zhu R; Luo Y; Li S; Wang Z
    Front Aging Neurosci; 2022; 14():1039780. PubMed ID: 36389074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
    Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
    Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.
    Thome AD; Standaert DG; Harms AS
    PLoS One; 2015; 10(10):e0140566. PubMed ID: 26469270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons.
    Rajbhandari L; Tegenge MA; Shrestha S; Ganesh Kumar N; Malik A; Mithal A; Hosmane S; Venkatesan A
    Glia; 2014 Dec; 62(12):1982-91. PubMed ID: 25042766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
    Filippini A; Gennarelli M; Russo I
    Cell Mol Neurobiol; 2019 Mar; 39(2):161-168. PubMed ID: 30637614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Galectin-3 in α-synuclein-induced microglial activation.
    Boza-Serrano A; Reyes JF; Rey NL; Leffler H; Bousset L; Nilsson U; Brundin P; Venero JL; Burguillos MA; Deierborg T
    Acta Neuropathol Commun; 2014 Nov; 2():156. PubMed ID: 25387690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system diseases related to pathological microglial phagocytosis.
    Wang K; Li J; Zhang Y; Huang Y; Chen D; Shi Z; Smith AD; Li W; Gao Y
    CNS Neurosci Ther; 2021 May; 27(5):528-539. PubMed ID: 33650762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X7 receptor is critical in α-synuclein--mediated microglial NADPH oxidase activation.
    Jiang T; Hoekstra J; Heng X; Kang W; Ding J; Liu J; Chen S; Zhang J
    Neurobiol Aging; 2015 Jul; 36(7):2304-2318. PubMed ID: 25983062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation.
    Rocha SM; Saraiva T; Cristóvão AC; Ferreira R; Santos T; Esteves M; Saraiva C; Je G; Cortes L; Valero J; Alves G; Klibanov A; Kim YS; Bernardino L
    J Neuroinflammation; 2016 Jun; 13(1):137. PubMed ID: 27260166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.